Moriteru Asano

Anti‐tumor efficacy of a novel CLK inhibitor via targeting RNA splicing and MYC‐dependent vulnerability

Kenichi Iwai, Masahiro Yaguchi, Kazuho Nishimura et al. · EMBO Molecular Medicine · 2018 · 89 citations · Full text

Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs) Part III: Discovery of 4-(5-oxopyrrolidine-1-yl)benzonitrile derivative 2f as a clinical candidate

Katsuji Aikawa, Moriteru Asano, Koji Ono et al. · Bioorganic & Medicinal Chemistry · 2017 · 40 citations · Full text

Medicinal Chemistry, Part Iii, Medicine +13

Chemical structure-guided design of dynapyrazoles, cell-permeable dynein inhibitors with a unique mode of action

Jonathan B. Steinman, Cristina Santarossa, Rand M. Miller et al. · eLife · 2017 · 40 citations · Full text

Combinatorial Chemistry, Unique Mode, Molecular Biology +23

Design and Synthesis of Potent Inhibitor of Apoptosis (IAP) Proteins Antagonists Bearing an Octahydropyrrolo[1,2-<i>a</i>]pyrazine Scaffold as a Novel Proline Mimetic

Kentaro Hashimoto, Bunnai Saito, Naoki Miyamoto et al. · Journal of Medicinal Chemistry · 2013 · 32 citations · Full text

Chemoprevention Strategy, Potent Inhibitor, Novel Proline Mimetic +19

Synthetic Studies toward GKK1032s, Novel Antibiotic Antitumor Agents:  Enantioselective Synthesis of the Fully Elaborated Tricyclic Core via an Intramolecular Diels−Alder Cycloaddition

Moriteru Asano, Munenori Inoue, Kazuhiro Watanabe et al. · The Journal of Organic Chemistry · 2006 · 29 citations